T3 Pharmaceuticals
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
T3 Pharmaceuticals has raised €23M across 1 funding round, most recently a round in Jul 2020. Based in Basel, Switzerland; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€23M
€23,277,467
Funding rounds
1
Investors
0
distinct backers
Active since
2020-07
latest 2020-07
Funding by year
EUR raised per yearT3 Pharmaceuticals — funding by year — interactive chart.
Data table
| T3 Pharmaceuticals — funding by year | |
|---|---|
| 2020 | €23M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-22 | Other | €23M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData